Close menu




March 20th, 2026 | 08:10 CET

Quality stocks at bargain prices: Almonty Industries, Rheinmetall and RENK

  • Mining
  • Tungsten
  • Defense
  • hightech
  • Investments
Photo credits: pixabay

Rising energy prices and fears of their economic consequences are putting increasing pressure on the global stock markets. What does the future hold amid growing geopolitical tensions and conflicts? While most industries face major challenges, there are clear winners: commodity producers and defense companies. Almonty Industries, in particular, looks extremely attractive during the current correction phase. As the world's leading tungsten producer outside of China, the company carries significant geopolitical importance. A recent major milestone further strengthens its position. Analysts are recommending the stock as a buy.

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: ALMONTY INDUSTRIES INC. | CA0203987072 | TSX: AII , NASDAQ: ALM , ASX: AII , RHEINMETALL AG | DE0007030009 , RENK AG O.N. | DE000RENK730

Table of contents:


    Almonty Industries – Milestone Reached

    Just a few days ago, Almonty shares hit a new all-time high of around USD 22. During the current period of market volatility, the shares fell sharply but are now rebounding. Most recently, Bank of America analysts raised their price target to USD 20.

    The company recently reached an important milestone, which apparently prompted some profit-taking. Almonty announced that Phase 1 of its flagship Sangdong mine in South Korea has now reached full production capacity. The mine is now processing 640,000 metric tons of tungsten ore annually, yielding approximately 2,300 metric tons of tungsten concentrate. The sharply increased prices play significantly in the company's favor. Currently, around USD 2,250 per metric ton unit (MTU) is being quoted. This corresponds to a price of roughly USD 225,000 per ton, implying enormous margin potential, as Sangdong was designed to operate profitably even in a low-price environment of USD 250 to USD 300 per MTU.

    Even more exciting and lucrative for shareholders will be the second phase of expansion, which, if all goes well, could be completed by the end of 2027. Production volume will then increase significantly once again, and Almonty will be able to cover 40% of global demand outside of China. According to CEO Lewis Black, this will enable Almonty to establish a fully integrated value chain for critical raw materials in South Korea, which would make the Asian country a global hub for the production, refining, and processing of tungsten. As a result, the company is likely to benefit greatly from the high demand from the defense sectors of Western industrialized nations. Due to its unique properties, tungsten is an essential raw material for several industries, particularly the defense sector.

    A few months ago, the US government announced plans to establish a strategic reserve for rare earths and other critical raw materials to support the national technology industry. Governments and states are thus increasingly establishing themselves as an important investor group willing to pay strategically motivated prices to ensure supply security.

    Rheinmetall – Berenberg Price Target: EUR 2,100

    Defense and drone IPOs are on the rise on the stock market. Defense supplier Vincorion is about to make its debut on the Frankfurt Stock Exchange. With an offering price of EUR 17, its market capitalization stands at around EUR 850 million. Vincorion manufactures mechatronics, generators, and other energy solutions. Vincorion's components are used in air defense systems and tanks, among other applications. Its customers include Rheinmetall and KNDS. The defense group KNDS also plans to go public this year, as CEO Jean-Paul Alary recently confirmed.

    Market leader Rheinmetall currently has a market capitalization of more than EUR 70 billion. Analysts at the private bank Berenberg recently reaffirmed their "Buy" rating and price target of EUR 2,100. Shares are currently trading at around EUR 1,550. Last year, the group generated revenue of just under EUR 10 billion. The company has projected revenues of around EUR 50 billion by 2030. To focus entirely on its core defense business, Rheinmetall has decided to divest its civilian business divisions. The separation will be completed in the current fiscal year. In addition, the group is actively engaged in M&A and is thus expanding into other fields such as naval, aerospace, and drones. The shares remain a core investment in the sector.

    RENK – Strategically Well-Positioned

    Even though defense stocks have been volatile in recent months, the current geopolitical situation clearly favors industry players. Defense budgets will continue to rise and lead to high profits. The stock market already priced in much of this last year, though a broad consolidation of defense stocks began in the fall. RENK is no exception. From highs of EUR 90, the stock has since fallen back to EUR 54. On average, analysts assign RENK an upside potential of around 20% over the next 12 months. Experts at Bank of America are significantly more optimistic, with a price target of EUR 75.

    On the stock market, the company is valued at approximately 3.8x and 3.2x the revenue expected for 2026 and 2027, respectively. Given the German company's strong market position, this is a reasonable level. RENK specializes in high-precision drive technology and transmission systems and is one of the most important suppliers in safety-critical industries.


    The current consolidation at Almonty offers a prime opportunity to invest or add to positions. Its market position as the world's largest tungsten producer outside of China gives the company geopolitical clout. Analysts recommend buying. Defense stocks such as Rheinmetall and RENK are also beneficiaries of a changing world.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by André Will-Laudien on April 13th, 2026 | 09:30 CEST

    Double The Gains: 100% Rebound in Defense Stocks and Critical Metals – Rheinmetall, Antimony Resources, CSG, and Mutares in focus

    • Mining
    • antimony
    • Defense
    • CriticalMetals
    • geopolitics
    • security

    Created and published on behalf of Antimony Resources Corp.

    The stock market gives and takes. While investors were able to celebrate a massive 5% gain last week, the tide has already turned in the opposite direction this week. The reason: The hoped-for peace talks in Pakistan between the US, Israel, and Iran have failed. Since this provides no positive momentum for the economy or the already strained energy and metals markets, volatility is likely to return in some sectors. We are looking at opportunities in the critical metals sector and highlighting some stocks that are showing attractive metrics again following recent corrections.

    Read

    Commented by Mario Hose on April 13th, 2026 | 07:30 CEST

    100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec

    • Biotechnology
    • Biotech
    • Pharma
    • Investments

    Even in the spring of 2026, the stock market remains highly volatile. The upheavals caused by geopolitical crises have been and remain significant and ever-present. While heavyweights like Bayer are struggling to shake off their legal baggage and Evotec is steering into calmer waters, a stock from the back row is suddenly stepping into the spotlight. Vidac Pharma has also had a few turbulent months, and this is precisely where experienced investors now sense an opportunity. With a current share price of EUR 0.56, the company is poised for a potential recovery, an uptick, and perhaps even a complete revaluation. If the strategy pays off, the EUR 1 mark could be reached. That would be a chance to double their money for bold investors. But what is behind this optimism? In this report, we take a look at the industry giants and analyze not only them but also why, of all three, the one with the smallest market capitalization could develop the greatest momentum. It is about potential breakthroughs in cancer research and a management team that is optimizing many aspects for success.

    Read

    Commented by André Will-Laudien on April 13th, 2026 | 07:25 CEST

    Almonty Drives the Tungsten Market: Between Shortages, Price Surges, and Revaluation

    • Mining
    • Tungsten
    • Defense
    • geopolitics
    • hightech

    Major stock indices are currently experiencing heightened volatility. Following the strong rally of the past 24 months, both the S&P 500 and the DAX 40 have recently corrected by between 5% and 10%. Rising interest rates and little prospect of peace in one of the many global hotspots are weighing particularly heavily on the market. Commodities paint a different picture: industrial metals and critical materials remain in demand, led by tungsten, whose price has increased roughly tenfold over the past 24 months. Producer Almonty Industries is benefiting particularly from this; with the start of production in Sangdong, it is now entering a new operational phase and, with a market capitalization of more than EUR 4.2 billion, has made its way onto the buy lists of institutional investors. The recent consolidation appears to be over. What should investors be watching for now?

    Read